9 April 2021: In section 3 we added a recommendation to follow advice on COVID-19 vaccination for patients having or going to be having immunosuppressive treatments. We also added a question on COVID-19 vaccination to recommendation 3.2.
30 April 2020: We added information to recommendation 4.5 to highlight that the half-life of some drugs means that immunosuppression will continue for some time after stopping treatment.
Minor changes since publication
21 May 2020: We aligned recommendation 1.8 with current government advice on social distancing.